Atlas Trials

Rifaximin Therapy in Chronic Kidney Disease

Clinical trial NCT02342639 · COMPLETED

Trial details

NCT number
NCT02342639
Sponsor
Jason Stubbs, MD
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2015-06-01
Primary completion
2019-03-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.